Skip to main content

UF Health Central Florida hospitals earn national recognition for stroke treatment

Hospital news | Wednesday, September 29, 2021

Contact: Andrea Sellers

UF Health Central Florida hospitals have been recognized by the American Heart Association and American Stroke Association for meeting the latest research-based standards for stroke care and continuing to improve the quality of patient care.

UF Health Leesburg Hospital has received the GOLD PLUS Get With The Guidelines® Stroke award with Target: Stroke ELITE Honor Roll and both UF Health Leesburg Hospital and UF Health The Villages® Hospital earned the GOLD PLUS Get With The Guidelines® Stroke award with Target: Type 2 Diabetes Honor Roll.

“These clinical achievement awards shine a light on the commitment our team has made to ensure that stroke patients receive high-quality care according to nationally recognized, research-based guidelines,” says Heather Long, M.S.N., chief operating officer for UF Health Central Florida. “We are honored to be recognized by the American Heart Association for our dedication to helping patients have the best possible chance of survival after a stroke.”

Stroke is the No. 5 cause of death and a leading cause of adult disability in the U.S. On average, someone in the U.S. suffers a stroke every 40 seconds, and nearly 795,000 people suffer a new or recurrent stroke each year. Early stroke detection and treatment are key to improving survival, minimizing disability and speeding recovery times.

Get With The Guidelines – Stroke was developed to assist health care professionals to provide the most up-to-date, research-based guidelines for treating stroke patients. Each year program participants apply for the award recognition by demonstrating how their organization follows treatment guidelines and provides education to patients to help them manage their health and rehabilitation once at home.

To qualify for the Target: Stroke ELITE Honor Roll award, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.

To qualify for the Target: Type 2 Diabetes Honor Roll award, hospitals must meet quality measures developed with more than 90% compliance for 12 consecutive months for the “Overall Diabetes Cardiovascular Initiative Composite Score.”